Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Cocco

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Frontiers in Cellular Neuroscience|June 20, 2017
Profiles of VGF Peptides in the Rat Brain and Their Modulations after Phencyclidine TreatmentBarbara Noli, Fabrizio Sanna, Carla Brancia, et al.
Plos One|February 25, 2017
Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gainJo E Lewis, John M Brameld, Phil Hill, et al.
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft|December 6, 2023
VGF modifications related to nigrostriatal dopaminergic neurodegeneration induced by the pesticide fipronil in adult male ratsElias Manca, Barbara Noli, Giulia Corda, et al.
Cells|February 25, 2022
Correction: Boiten et al. Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF. <i>Cells</i> 2021, <i>10</i>, 38Walter A Boiten, Inger van Steenoven, Mei-Fang Xiao, et al.
Cells|January 1, 2021
Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGFWalter A Boiten, Inger van Steenoven, Mei-Fang Xiao, et al.
Plos One|November 13, 2015
VGF Peptide Profiles in Type 2 Diabetic Patients' Plasma and in Obese MiceFilomena D'Amato, Barbara Noli, Laura Angioni, et al.
Neuropsychobiology|September 8, 2024
Lower Plasma Levels of Selective VGF (Non-Acronymic) Peptides in Bipolar Disorder: Comparative Analysis Reveals Distinct Patterns across Mood Disorders and Healthy ControlsCristina Cocco, Barbara Noli, Barbara Manconi, et al.
Cell and Tissue Research|November 13, 2019
VGF peptides as novel biomarkers in Parkinson's diseaseCristina Cocco, Giulia Corda, Carlo Lisci, et al.
Plants (Basel, Switzerland)|November 13, 2025
Inhibition of α-Glucosidase Activity and Islet Amyloid PolyPeptide Fibril Formation by <i>Rubus</i><i>ulmifolius</i> Fruit Extract: A Potential Therapeutic Approach for Type 2 Diabetes MellitusSonia Floris, Barbara Noli, Cristina Cocco, et al.
Neurochemical Research|October 30, 2025
Early Dopaminergic Dysfunction Induces PRO-VGF Changes in Blood and Brain of Rats with Alpha-Synuclein OverexpressionElias Manca, Sara Corsi, Silvia Fanni, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Frontiers in Cellular Neuroscience|June 20, 2017
Profiles of VGF Peptides in the Rat Brain and Their Modulations after Phencyclidine TreatmentBarbara Noli, Fabrizio Sanna, Carla Brancia, et al.
Plos One|February 25, 2017
Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gainJo E Lewis, John M Brameld, Phil Hill, et al.
Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft|December 6, 2023
VGF modifications related to nigrostriatal dopaminergic neurodegeneration induced by the pesticide fipronil in adult male ratsElias Manca, Barbara Noli, Giulia Corda, et al.
Cells|February 25, 2022
Correction: Boiten et al. Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF. <i>Cells</i> 2021, <i>10</i>, 38Walter A Boiten, Inger van Steenoven, Mei-Fang Xiao, et al.
Cells|January 1, 2021
Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGFWalter A Boiten, Inger van Steenoven, Mei-Fang Xiao, et al.
Plos One|November 13, 2015
VGF Peptide Profiles in Type 2 Diabetic Patients' Plasma and in Obese MiceFilomena D'Amato, Barbara Noli, Laura Angioni, et al.
Neuropsychobiology|September 8, 2024
Lower Plasma Levels of Selective VGF (Non-Acronymic) Peptides in Bipolar Disorder: Comparative Analysis Reveals Distinct Patterns across Mood Disorders and Healthy ControlsCristina Cocco, Barbara Noli, Barbara Manconi, et al.
Cell and Tissue Research|November 13, 2019
VGF peptides as novel biomarkers in Parkinson's diseaseCristina Cocco, Giulia Corda, Carlo Lisci, et al.
Plants (Basel, Switzerland)|November 13, 2025
Inhibition of α-Glucosidase Activity and Islet Amyloid PolyPeptide Fibril Formation by <i>Rubus</i><i>ulmifolius</i> Fruit Extract: A Potential Therapeutic Approach for Type 2 Diabetes MellitusSonia Floris, Barbara Noli, Cristina Cocco, et al.
Neurochemical Research|October 30, 2025
Early Dopaminergic Dysfunction Induces PRO-VGF Changes in Blood and Brain of Rats with Alpha-Synuclein OverexpressionElias Manca, Sara Corsi, Silvia Fanni, et al.
Pageof 5